Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 65 Results
December 17, 2024 | Video
Advancing precision medicine in lymphoma with ctDNA-MRD – presentation by Dr. Mark Roschewski (NCI/NIH)
December 13, 2024 | Poster
The clinical impact and cost-effectiveness of PET-based and ctDNA-based evaluation at end of therapy for frontline treatment of DLBCL
ASH
December 13, 2024 | Poster
Mosunetuzumab Plus Polatuzumab Vedotin Induces Early Complete Responses in Previously Untreated High Tumor Burden Follicular Lymphoma
ASH
December 13, 2024 | Poster
Using Circulating Tumor DNA to Spare Patients with Diffuse Large B-cell Lymphoma Unnecessary Treatment and Cost: a Model-based Analysis
ASH
December 13, 2024 | Poster
Circulating tumor DNA clearance by neoadjuvant chemotherapy or breast surgery detected using an ultra-sensitive ctDNA MRD assay in early breast cancer
SABCS
December 12, 2024 | Presentation
Baseline prognostic factors do not predict end of treatment ctDNA MRD status and have limited impact on MRD prognostic performance in DLBCL
ASH